G

GemVax & KAEL Co Ltd
KOSDAQ:082270

Watchlist Manager
GemVax & KAEL Co Ltd
KOSDAQ:082270
Watchlist
Price: 27 650 KRW -1.43% Market Closed
Market Cap: 1.2T KRW

Wall Street
Price Targets

Price Targets Summary
GemVax & KAEL Co Ltd

There are no price targets for GemVax & KAEL Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
GemVax & KAEL Co Ltd Competitors:
Price Targets
GREATEC
Greatech Technology Bhd
45% Upside
688037
Kingsemi Co Ltd
12% Downside
240810
Wonik IPS Co Ltd
29% Upside
6146
Disco Corp
18% Upside
603688
Jiangsu Pacific Quartz Co Ltd
21% Upside
2455
Visual Photonics Epitaxy Co Ltd
44% Upside
348210
Nextin Inc
12% Upside
AWX
Aem Holdings Ltd
9% Upside

Revenue
Forecast

Revenue Estimate
GemVax & KAEL Co Ltd

For the last 13 years the compound annual growth rate for GemVax & KAEL Co Ltd's revenue is 1%. The projected CAGR for the next 4 years is -7%.

1%
Past Growth
-7%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
GemVax & KAEL Co Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
GemVax & KAEL Co Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GemVax & KAEL Co Ltd's stock price target?
Not Available

GemVax & KAEL Co Ltd doesn't have any price targets made by Wall Street professionals.

What is GemVax & KAEL Co Ltd's Revenue forecast?
Projected CAGR
-7%

For the last 13 years the compound annual growth rate for GemVax & KAEL Co Ltd's revenue is 1%. The projected CAGR for the next 4 years is -7%.

Back to Top